| Symbol |
Name |
|
ACVR2A
|
activin A receptor, type IIA
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
AFP
|
alpha-fetoprotein
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ATM
|
ATM serine/threonine kinase
|
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
|
C3
|
complement component 3
|
|
CBS
|
cystathionine-beta-synthase
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHST8
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8
|
|
CLOCK
|
clock circadian regulator
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP7B1
|
cytochrome P450, family 7, subfamily B, polypeptide 1
|
|
DDX20
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 20
|
|
DRD2
|
dopamine receptor D2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
FANCL
|
Fanconi anemia, complementation group L
|
|
FOXA2
|
forkhead box A2
|
|
FOXN1
|
forkhead box N1
|
|
FOXO3
|
forkhead box O3
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
|
GHR
|
growth hormone receptor
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GPR149
|
G protein-coupled receptor 149
|
|
GPR3
|
G protein-coupled receptor 3
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL5
|
interleukin 5
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INSL5
|
insulin-like 5
|
|
IRS2
|
insulin receptor substrate 2
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KISS1R
|
KISS1 receptor
|
|
LATS1
|
large tumor suppressor kinase 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LHX9
|
LIM homeobox 9
|
|
MAGEL2
|
melanoma antigen family L2
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NHLH2
|
nescient helix loop helix 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2
|
|
NTF3
|
neurotrophin 3
|
|
PCSK6
|
proprotein convertase subtilisin/kexin type 6
|
|
PER1
|
period circadian clock 1
|
|
PER2
|
period circadian clock 2
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
PRL
|
prolactin
|
|
PTPRS
|
protein tyrosine phosphatase, receptor type, S
|
|
RORA
|
RAR-related orphan receptor A
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SIRT1
|
sirtuin 1
|
|
SRY
|
sex determining region Y
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIPARP
|
TCDD-inducible poly(ADP-ribose) polymerase
|
|
TNF
|
tumor necrosis factor
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
UBE2Q1
|
ubiquitin-conjugating enzyme E2Q family member 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VGF
|
VGF nerve growth factor inducible
|
